Hyperactivity
Laughter and happiness
Mental Deficiency and Developmental Testing
Autism and Related Traits
Speech and Language
Communication
Sleep Disorders
Sexuality
Seizures
Central Nervous System Structure
Gastrointestinal Issues and Oral-motor Behaviors
Gait and Movement Disorders
Surgical Procedures and Anesthesia
Temperature Sensitivity
Physical Growth
Hypopigmentation, Strabismus and Ocular Albinism
Children with Angelman Syndrome (AS) present many unique physical, social, educational, cognitive, and communicative challenges which require interventions to be comprehensive in nature and scope.
Young adults with AS continue to learn and are generally not expected to have deterioration in their mental abilities.
Source: 7th edition Facts about Angelman Syndrome by Charles A. Williams, M.D., Sarika U. Peters, Ph.D., Stephen N. Calculator, Ph.D. in 2009 In the event of any discrepancy, the English original shall prevail. Special thanks to SPEAR Translation sponsors and provides Chinese translation.
Ovid Therapeutic, a biopharmaceutical company in USA announced a development of a medicine to transform the live of people with neurological disease. at the same time, and University of Connecticut School of Medicine, USA begins a research collaboration to accelerate the development of a next-generation short hairpin RNA (shRNA)-based therapeutic for Angelman syndrome and potentially other indications.
It is a very good news to Angelman and also other Families with rare disease. Please click the below hyperlink for more detail.
Chinese Version for Global Angelman Syndrome Registry is available. Global Angelman Syndrome Registry